InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…
(TheNewswire) Brossard (Québec), le 18 septembre 2025 – TheNewswire – CORPORATION CHARBONE HYDROGÈNE (TSXV: CH,OTC:CHHYF , OTCQB: CHHYF, FSE: K47…